Symbol | Exchange | Currency |
|---|
Investing.com – U.S. stocks were higher after the close on Friday, as gains in the Basic Materials, Technology and Industrials sectors led shares higher. At the close in NYSE, the...
Investing.com – U.S. stocks were lower after the close on Tuesday, as losses in the Industrials, Oil & Gas and Technology sectors led shares lower. At the close in NYSE, the Dow...
Investing.com – U.S. stocks were higher after the close on Friday, as gains in the Telecoms, Technology and Consumer Services sectors led shares higher. At the close in NYSE, the...
Tenax Therapeutics, Inc. is a specialty pharmaceutical company focused on identifying and developing therapeutics that address cardio-pulmonary diseases with high unmet medical need. The Company's products include TNX-103 (oral levosimendan) and TNX-201 (oral enteric coated imatinib). The Company's lead product, Levosimendan, is a calcium sensitizer/K-ATP activator developed for intravenous use in hospitalized patients with acutely decompensated heart failure. TNX-201 is for the treatment of pulmonary arterial hypertension (PAH), which is a fatal orphan disease. The Company has completed Phase II clinical trial of levosimendan in North America for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction (PH-HFpEF).
| Average | 90.0000 (+5,042.8571% Upside) |
| High | 100.0000 |
| Low | 80.0000 |
| Price | 1.7500 |
| No. of Analysts | 2 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Sell | Strong Sell | Strong Sell |
| Technical Indicators | Buy | Neutral | Sell | Strong Sell | Strong Sell |
| Summary | Neutral | Sell | Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 84.50 | 86.97 | 83.62 | +3.11 | +3.82% | 12.79M | NASDAQ | |||
| 106.33 | 109.53 | 105.81 | -3.41 | -3.11% | 15.98M | NYSE | |||
| 186.53 | 196.77 | 182.89 | -2.24 | -1.19% | 76.54M | NASDAQ | |||
| 5.65 | 5.74 | 5.01 | +0.7100 | +14.37% | 66.65K | NASDAQ | |||
| 6.08 | 6.77 | 6.03 | 0.00 | 0.00% | 52.35M | NYSE | |||
| 1.76 | 1.842 | 1.76 | -0.050 | -2.76% | 22.80K | NASDAQ | |||
| 35.47 | 35.75 | 34.49 | +0.45 | +1.28% | 10.03K | NASDAQ | |||
| 11.01 | 11.37 | 11.01 | -0.14 | -1.26% | 8.29K | NYSE | |||
| 18.87 | 19.13 | 18.57 | -0.22 | -1.15% | 78.75K | NASDAQ | |||
| 11.71 | 11.75 | 11.30 | +0.290 | +2.54% | 50.32K | NYSE | |||
| 12.49 | 13.50 | 12.32 | -0.48 | -3.70% | 10.23M | NYSE | |||
| 8.97 | 9.35 | 8.97 | -0.06 | -0.66% | 5.08K | NASDAQ | |||
| 44.06 | 44.39 | 43.88 | -0.28 | -0.63% | 23.71M | NYSE | |||
| 23.4499 | 23.4499 | 23.4499 | 0.00 | 0.00% | 100.00 | OTC Markets | |||
| 0.20 | 0.20 | 0.20 | -0.00 | -0.27% | 127.66K | OTC Markets |